Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2019-10-02 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in the company's capital structure and share issuance activities during a specific month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements to the stock exchange, consistent with a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement of a report.
2019-10-02 English
Interim Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2019' and contains detailed financial information for the six months ended 30 June 2019, including unaudited interim financial statements such as condensed consolidated statements of profit or loss, comprehensive income, financial position, changes in equity, and cash flows. It also includes management discussion and analysis, business review, financial review, and other corporate information. The presence of actual financial data and analysis for a period shorter than a full fiscal year (six months) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it is not merely an announcement or certification, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2019
2019-09-26 English
List of Directors and their Roles and Functions
Board/Management Information Classification · 100% confidence The document lists the names and roles of the board of directors and board committees of Guangdong Tannery Limited, effective from a specific date. It is an announcement about the composition and structure of the company's board and committees, which fits the category of Board/Management Information. The document is short and does not contain financial data or other report content, so it is not an annual report or similar. Therefore, the appropriate classification is MANG (Board/Management Information).
2019-09-02 English
Re-Designation of Director and Change of Chairman and Chairman of the Nomination Committee
Board/Management Information Classification · 100% confidence The document is an announcement from the Board of Guangdong Tannery Limited regarding changes in the board composition, specifically the re-designation of a director and changes in the chairman and chairman of the nomination committee. It details the personal particulars of the director involved and the effective date of the changes. There is no financial data, no report attached or referenced as being published, and no mention of earnings or other financial results. The content clearly fits the category of announcements about changes in the company's board or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (5558 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2019-09-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/08/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and confirmations related to securities issued during the month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements to the exchange, consistent with regulatory compliance disclosures rather than a financial report or announcement of a report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-09-02 English
Interim Results Announcement for the six months ended 30 June 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2019' and contains detailed unaudited condensed consolidated financial statements including profit or loss, comprehensive income, and financial position for the six months ended 30 June 2019. It references accounting policies consistent with interim reporting standards (HKAS 34) and includes comparative figures for the prior period. The length is substantial (15,000 characters) and the content includes substantive financial data and analysis, not merely an announcement or certification. Therefore, this document is a comprehensive interim financial report for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-26 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.